Clobetasol Propionate Foam — Class III drug recall D-0619-2020
Terminated recall by Glenmark Pharmaceuticals Inc., USA, reported 2019-12-18, distributed nationwide. Defective delivery system; product is not foaming or is coming out as liquid.
| Recall number | D-0619-2020 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ, United States |
| Recall initiated | 2019-11-15 |
| Classified | 2019-12-10 |
| Reported by FDA | 2019-12-18 |
| Terminated | 2024-03-15 |
| Distributed | Nationwide (US) |
| NDC | 68462-0625, 68462-0625-27, 68462-0625-94 |
| Lot numbers | 14190067, JUL-2021 |
Product
Clobetasol Propionate Foam (Emulsion Formulation), 0.05% a) 50 g pack (NDC 68462-625-27) and b) 100 g pack (NDC 68462-625-94), Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited Plot No. B-25, MIDC, Shendra Aurangabad, Maharashtra -431210, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430
Reason for recall
Defective delivery system; product is not foaming or is coming out as liquid.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0619-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.